|
【结 构 式】 
|
【药物名称】 【化学名称】N-[3(R)-Hydroxytetradecanoyl]-L-seryl-4-(5-methyl-2-oxo-1,3-dioxol-4-ylmethoxycarboxamido)-D-2-aminobutyryl-L-aspartyl-N6-(5-methyl-2-oxo-1,3-dioxol-4-ylmethoxycarboxamido)-L-lysyl-4-(5-methyl-2-oxo-1,3-dioxol-4-ylmethoxycarboxamido)-L-2-aminobutyryl-L-allothreonyl-(Z)-2,3-didehydro-2-aminobutyryl-3(S)-hydroxy-L-aspartyl-4-chloro-L-threonine C-1.9-O-3.1-lactone 【CA登记号】 【 分 子 式 】C69H99ClN12O34 【 分 子 量 】1676.07138 |
【开发单位】Lilly (Originator) 【药理作用】Antifungal Agents, ANTIINFECTIVE THERAPY, Chemical Delivery Systems, DRUG DELIVERY, Drug Delivery Systems |
合成路线1
The acylating reagent (V) was prepared as follows. Allylic bromination of 4,5-dimethyl-1,3-dioxolene-2-one (I) with N-bromosuccinimide afforded bromide (II). This was converted to alcohol (IV) via formation of the formate ester (III), followed by acidic hydrolysis. Reaction of (IV) with p-nitrophenyl chloroformate and pyridine furnished carbonate (V). The acylation of pseudomycin B (VI) with carbonate (V) produced a mixture of mono-, di- and triacylated compounds from which the desired tricarbamate was isolated by reverse-phase preparative HPLC.
| 【1】 Sun, X.; et al.; Synthesis and evaluation of oxodioxolenylmethyl carbamate prodrugs of pseudomycins. J Med Chem 2001, 44, 16, 2671. |
| 【2】 Chen, S.H.; Sun, X.D.; Rodriguez, M.J. (Eli Lilly and Company); Pseudomycin prodrugs. WO 0105813 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 31106 | 4,5-dimethyl-1,3-dioxol-2-one | 37830-90-3 | C5H6O3 | 详情 | 详情 |
| (II) | 13462 | 4-(Bromomethyl)-5-methyl-1,3-dioxol-2-one | 80715-22-6 | C5H5BrO3 | 详情 | 详情 |
| (III) | 50467 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl formate | C6H6O5 | 详情 | 详情 | |
| (IV) | 50468 | 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one | C5H6O4 | 详情 | 详情 | |
| (V) | 25503 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate | C12H9NO8 | 详情 | 详情 | |
| (VI) | 50469 | (2S)-2-((3S,6S,12S,15S,18S,21S,24R,27S)-18-(4-aminobutyl)-15,24-bis(2-aminoethyl)-21-(carboxymethyl)-3-[(1S)-2-chloro-1-hydroxyethyl]-9-[(Z)ethylidene]-12-[(1S)-1-hydroxyethyl]-27-[[(3R)-3-hydroxytetradecanoyl]amino]-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octaazacyclooctacosan-6-yl)-2-hydroxyethanoic acid | C51H87ClN12O19 | 详情 | 详情 |